Dr. Henry J. Esber serves as the Senior Vice President and the Chief Business Development Officer of Bio-Quant. Previous appointments included the executive director of business development at Charles Rivers laboratories and was the director of the Department of Immunology and Clinical services at TSI Mason. Dr. Esber has more than 25 years experience in the areas of tumor immunology, immunotherapy, toxicology, and immunotoxicology, and has published over 130 papers. He is also a full member in various scientific societies and associations.